Sino Biological's low ROE and high payout ratio pose signifi...
Sino Biological's low ROE and high payout ratio pose significant risks. The lack of reinvestment and growth isn't surprising. Analysts, however, expect future earnings growth despite past shrinkage.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000171fc266029856.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment